This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Thankfully, the COVID-19 vaccines that are currently being distributed — ones based on the original virus spike sequence — are effective in inducing immunity to the new strain.
The ASHRAE Epidemic Task Force has released new guidance to address control of airborne infectious aerosol exposure and recommendations for communities of faith buildings.
Earlier this year, SmithGroup's Science & Technology Practice hosted a guided client engagement charrette exploring key drivers, current trends, challenges, and opportunities as well as what the future holds. Here are the results.